Azar Sadat Rezapour Javareshk
-
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8(+) T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal
adenocarcinoma
Azar Rezapour, Daniel Rydbeck, Fabian Byvald, Viktor Tasselius, G. Danielsson, Eva Angenete, Ulf Yrlid
OncoImmunology - 2023 -
A Fraction of CD8+T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T
Cells
Frank Liang, Lisa M Nilsson, Fabian Byvald, Azar Rezapour, Helena Taflin, Jonas A Nilsson, Ulf Yrlid
Cancers - 2022 -
Cryopreservation of Whole Tumor Biopsies from Rectal Cancer Patients Enable Phenotypic and In Vitro Functional Evaluation of Tumor-Infiltrating T
Cells
Frank Liang, Azar Rezapour, Peter Falk, Eva Angenete, Ulf Yrlid
Cancers - 2021 -
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T
Cells.
Frank Liang, Azar Rezapour, Louis Szeponik, Samuel Alsén, Yvonne Wettergren, Elinor Bexe-Lindskog, Marianne Quiding-Järbrink, Ulf Yrlid
Cancers - 2021